Lung cancer stage-shift following a symptom awareness campaign
Authors:
Abstract
Background: Lung cancer outcomes in the UK are worse than in many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage to improve cancer outcomes.Methods: An early diagnosis campaign for lung cancer commenced in Leeds, UK in 2011 comprising public and primary-care facing components. Rates of community referral for chest X-ray and lung cancer stage (TNM seventh edition) at presentation were collected from 2008 to 2015. Linear trends were assessed by χ2 test for trend in proportions. Headline figures are presented for the 3 years pre-campaign (2008–2010) and the three most recent years for which data are available during the campaign (2013–2015).Findings: Community-ordered chest X-ray rates per year increased from 18 909 in 2008–2010 to 34 194 in 2013–2015 (80.8% increase). A significant stage shift towards earlier stage lung cancer was seen (χ2(1)=32.2, p<0.0001). There was an 8.8 percentage point increase in the proportion of patients diagnosed with stage I/II lung cancer (26.5% pre-campaign vs 35.3% during campaign) and a 9.3% reduction in the absolute number of patients diagnosed with stage III/IV disease (1254 pre-campaign vs 1137 during campaign).Interpretation: This is the largest described lung cancer stage-shift in association with a symptom awareness campaign. A causal link between the campaign and stage-shift cannot be proven but appears plausible. Limitations of the analysis include a lack of contemporary control population.Keywords
Funding Information
- UK National Awareness and Early Diagnosis Initiative
- Leeds City Council
- NHS Leeds Clinical Commissioning Groups
- NHS Leeds Primary Care Trusts
This publication has 14 references indexed in Scilit:
- Apples and pears? A comparison of two sources of national lung cancer audit data in EnglandERJ Open Research, 2017
- Is England closing the international gap in cancer survival?British Journal of Cancer, 2015
- An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptomBritish Journal of Cancer, 2014
- Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based studyThe Lancet Oncology, 2014
- Emergency presentation of cancer and short-term mortalityBritish Journal of Cancer, 2013
- Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007Thorax, 2013
- Routes to diagnosis for cancer – determining the patient journey using multiple routine data setsBritish Journal of Cancer, 2012
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataThe Lancet, 2011
- National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-upThorax, 2010
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 studyThe Lancet Oncology, 2007